For Better or Worse: Clinical Correlation of SOX9 and Irradiated Rectal Cancer Xiuzhen Duan, Brandon Trac, and Xianzhong Ding, Department of Pathology Loyola University Medical Center Maywood, IL 60153 USA
SOX9 and Cancer Stem-like Cells • it is well accepted that cancer stem-like cells are the main driving force behind tumor formation, metastasis, and chemoresistance • Cancer stem like cells exhibit diverse cell properties including self renewal, differentiation capacity, and resistance to apoptosis and chemotherapy
SOX9 • Sex-determining region Y (SRY)-box 9 protein (SOX9) is a member of the SOX family of transcription factors • SOX9 participates in a variety of functions, such as tumor cell differentiation, stem-like cell lineage formation and epithelial mesenchymal transition • Role of SOX9 in colon cancer: controversial • Effect of chemoradiation on SOX9 expression unclear
Aims and Methods • The objectives of this study is examining SOX9 expression in pre- and post-irradiated rectal cancer • 25 patients with locally advanced rectal cancer – Moderately differentiated adenocarcinoma – Received neoadjuvant chemoradiation therapy followed by surgery
Aims and Methods • SOX9 expression – Evaluated by IHC – 4-tier grading system • 0: no expression • 1: low expression • 2: moderate expression • 3: high expression – Percentage of SOX9 positive cells
Pre-CRT post-CRT Pre-CRT post-CRT Non-tumor mucosa Adenocarcinoma
Pre-CRT post-CRT Pre-CRT post-CRT Non-tumor mucosa Adenocarcinoma
SOX9 expression and tumor response to neoadjuvant therapy • 2 cases with complete response to neoadjuvant therapy – High expression of SOX9 • No correlation of tumor volume reduction and SOX9 expression prior to chemotherapy • No association with lymph node metastasis and late distant metastasis
Conclusions • Role of SOX9 in colon cancer is still controversial • Might be a potential marker to predict tumor response to chemoradiation and oncological outcomes • Large cohort studies are needed to be conclusive
CORRELATION AND REGRESSION Correlation Course Title Correlation
Why No Worse Off is Worse Off John Aycock John Sullins
International Journal of Obstetrics and Gynaecology Research (IJOGR) Vol. 3
GoBackwards Go, but worse. Much worse. Shaquan Nelson (sdn2115) Julian
Today bivariate correlation bivariate regression multiple regression
: ESTIMATES AND TESTS Business Statistics CONTENTS The correlation
THE SAFETY OF RIDING GEAR WHAT TO CONSIDER WHEN PICKING PROTECTIVE APPAREL
1 Outline Introduction to WMSNs Spatial correlation for visual information
Correlation Quantitative A Aptitude & & Business S Statistics
DEPARTMENT OF COMMERCE WORSE CASE SCENARIO IN THE DATABASE WORSE CASE
Rogers C, et al., J Community Med Public Health Care 2017, 4: 032 DOI:
EDRN BIOMARKER DEVELOPMENT Sam Hanash Fred Hutchinson Cancer Research Center
We want to save patients with severe cancer and autoimmune diseases Clinical
CONSIDERATIONS IN DEVELOPMENT OF PEMBROLIZUMAB IN MSI-H CANCERS December 2017
Achievements: Poster Presentations in 2019 Leptomeningeal metastasis: A A
Cancer of Unknown Primary Helen Rickards Acute Oncology and Cancer of
Unusual Subtypes of Prostate Tumors Jonathan I. Epstein Financial and Other
Collecting Cancer Data: Pancreas 1/5/12 Collecting Cancer Data: Pancreas
Slide Presentation (SL-26): Pulmonary Pathology Jae Y. Ro, M.D., PhD Weill
The Role of the Experimental Therapeutics and Rare Tumor Committee (ETRTC) in
Advancing Precision Cancer Medicine: Novel Markers, Tests, Trials, and
Colon Cancer: Treatment and Prevention Presented by Dr. Yen Chen, Snoqualmie